ArticleCancer medicine2025

Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1-Mutated Acute Myeloid Leukemia.

Yiming Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.